Yuansheng Hu - Concepedia

Author

Yuansheng Hu

Sinovac Biotech

Also Known As

Hu Yuansheng, Wenguo Xu, Yuan-Sheng Hu, Yuan-sheng Hu, Yuansheng Hu

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Sinovac Biotech National Institutes for Food and Drug Control Jiangsu Provincial Center for Disease Control and Prevention Air Force Medical University Center for Disease Control

About

Yuansheng Hu is an author at Sinovac Biotech specializing in vaccination, vaccine safety, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	154
2	Immunology	4	4	154
3	Epidemiology	2	2	109
4	Public Health	1	1	95
5	Clinical Epidemiology	1	1	95

Yuansheng Hu

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Yanjun Zhang, Gang Zeng, Hongxing Pan, The Lancet Infectious Diseases	2020	1.5K
Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China Fengcai Zhu, Wenbo Xu, Jielai Xia, New England Journal of Medicine	2014	458
A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers Ran Liu, Lei He, Yuansheng Hu, Chemical Science	2020	105
Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial Yanjun Zhang, Gang Zeng, Hongxing Pan, Placebo-controlled Phase 2ImmunologyVaccine HesitancyCovid-19Influenza Vaccines	2020	95
Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children Jingxin Li, Yufei Song, Ling Wang, Expert Review of Vaccines	2015	72
Translating daily COVID-19 screening into a simple glucose test: a proof of concept study Ran Liu, Yuansheng Hu, Ying He, Chemical Science	2021	62
Hepatitis A Surveillance and Vaccine Use in China From 1990 Through 2007 Fuqiang Cui, Stephen C. Hadler, Hui Zheng, Journal of Epidemiology	2009	61
Immunogenicity, Safety, and Immune Persistence of a Novel Inactivated Human Enterovirus 71 Vaccine: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial Yanping Li, Zhenglun Liang, Jielai Xia, The Journal of Infectious Diseases	2013	52
Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial Kai Chu, Zhifang Ying, Ling Wang, Vaccine VaccinationVaccine SafetySabin StrainsVaccine DevelopmentImmunology	2018	30
Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine Zhilun Zhang, Xiang-jun Zhu, Yuansheng Hu, Human Vaccines & Immunotherapeutics	2017	17

Page 1